https://streamed-up.com/short/lecanemab-in-early-alzheimers-diseasehttps://streamed-up.com/short/donanemab-in-early-symptomatic-alzheimer-disease-the-trailblazer-alz-2-randomized-clinical-trialhttps://streamed-up.com/short/efficacy-and-safety-of-proposed-biosimilar-natalizumab-pb006-in-patients-with-relapsing-remitting-multiple-sclerosis-hexal-partner-shorthttps://streamed-up.com/short/continuous-subcutaneous-foslevodopafoscarbidopa-in-parkinsons-disease-safety-and-efficacy-results-from-a-12-month-single-arm-open-label-phase-3-study-abbvie-partner-shorthttps://streamed-up.com/short/safety-and-efficacy-of-continuous-subcutaneous-foslevodopa-foscarbidopa-in-patients-with-advanced-parkinsons-disease-a-randomised-double-blind-active-controlled-phase-3-trial-abbvie-partner-shorthttps://streamed-up.com/short/efficacy-and-safety-of-ravulizumab-a-complement-c5-inhibitor-in-adults-with-amyotrophic-lateral-sclerosishttps://streamed-up.com/short/early-versus-later-anticoagulation-for-stroke-with-atrial-fibrillation-results-of-the-elan-trialhttps://streamed-up.com/short/phase-2-trial-of-baxdrostat-for-treatment-resistant-hypertensionhttps://streamed-up.com/short/amylyx-partner-short-analysis-of-sodium-phenylbutyrate-and-taurursodiol-survival-effect-in-als-using-external-controlshttps://streamed-up.com/short/extracorporeal-life-support-in-infarct-related-cardiogenic-shockhttps://streamed-up.com/short/anticoagulation-with-edoxaban-in-patients-with-atrial-high-rate-episodeshttps://streamed-up.com/short/dupilumab-for-copd-with-type-2-inflammation-indicated-by-eosinophil-countshttps://streamed-up.com/short/efficacy-and-safety-of-a-targeted-release-formulation-of-budesonide-in-patients-with-primary-iga-nephropathy-nefigard-2-year-results-from-a-randomised-phase-3-trialhttps://streamed-up.com/short/lumasiran-an-rnai-therapeutic-for-primary-hyperoxaluria-type-1https://streamed-up.com/short/upadacitinib-induction-and-maintenance-therapy-for-crohns-diseasehttps://streamed-up.com/short/severe-hyponatremia-correction-mortality-and-central-pontine-myelinolysishttps://streamed-up.com/short/two-year-outcomes-of-valoctocogene-roxaparvovec-therapy-for-hemophilia-ahttps://streamed-up.com/short/efficacy-and-safety-of-early-administration-of-4-factor-prothrombin-complex-concentrate-in-patients-with-trauma-at-risk-of-massive-transfusion-the-procoag-randomized-clinical-trialhttps://streamed-up.com/short/molecular-residual-disease-and-efficacy-of-adjuvant-chemotherapy-in-patients-with-colorectal-cancerhttps://streamed-up.com/short/keynote-671-randomized-double-blind-phase-3-study-of-pembrolizumab-or-placebo-plus-platinum-based-chemotherapy-followed-by-resection-and-pembrolizumab-or-placebo-for-early-stage-nsclchttps://streamed-up.com/short/cardiovascular-and-cancer-risk-with-tofacitinib-in-rheumatoid-arthritishttps://streamed-up.com/short/atezolizumab-for-advanced-alveolar-soft-part-sarcomahttps://streamed-up.com/short/abbvie-partner-short-long-term-observational-results-from-the-aspire-study-onabotulinumtoxina-treatment-for-adult-lower-limb-spasticityhttps://streamed-up.com/short/abbvie-partner-short-an-open-label-prospective-study-of-the-real-life-use-of-onabotulinumtoxina-for-the-treatment-of-chronic-migraine-the-repose-study-2https://streamed-up.com/short/rilzabrutinib-an-oral-btk-inhibitor-in-immune-thrombocytopeniahttps://streamed-up.com/short/axicabtagene-ciloleucel-as-second-line-therapy-for-large-b-cell-lymphomahttps://streamed-up.com/short/abbvie-partner-short-individualized-onabotulinumtoxina-treatment-for-upper-limb-spasticity-resulted-in-high-clinician-and-patient-reported-satisfaction-long-term-observational-results-from-the-aspire-study-2https://streamed-up.com/short/abbvie-partner-short-effectiveness-of-onabotulinumtoxina-for-the-preventive-treatment-of-chronic-migraine-a-meta-analysis-on-10-years-of-real-world-data-2https://streamed-up.com/short/updated-results-from-avenance-real-world-effectiveness-of-avelumab-first-line-maintenance-in-patients-with-advanced-urothelial-carcinoma-and-analysis-of-subsequent-treatmenthttps://streamed-up.com/short/gentherapie-der-hamophilie-a-mit-valoctocogen-roxaparvovechttps://streamed-up.com/short/cd40l-inhibition-mit-frexalimab-zur-therapie-der-multiplen-sklerosehttps://streamed-up.com/short/first-line-serplulimab-versus-placebo-jeweils-in-kombination-mit-chemotherapie-beim-fortgeschrittenen-kleinzelligen-lungenkarzinomhttps://streamed-up.com/short/wirksamkeit-und-vertraglichkeit-von-bimekizumab-bei-patientinnen-mit-mittelschwerer-bis-schwerer-hidradenitis-suppurativahttps://streamed-up.com/short/retrospektive-studiendaten-zur-krankheitslast-von-erwachsenen-durch-rsv-im-vergleich-zu-influenzahttps://streamed-up.com/short/ixekizumab-bei-radiografischer-axialer-spondyloarthritis-mit-oder-ohne-objektivierbare-inflammationszeichenhttps://streamed-up.com/short/pradiktives-model-zur-wahrscheinlichkeit-eines-initialen-ansprechens-auf-tnf-inhibitoren-bei-radiografischer-axialer-spondyloarthritishttps://streamed-up.com/short/tezepelumab-in-der-therapie-der-schweren-chronischen-rhinosinusitis-mit-nasalen-polypenhttps://streamed-up.com/short/garadacimab-faktor-xiia-inhibition-als-therapeutischer-ansatzpunkt-in-der-therapie-des-hereditaren-angioodemshttps://streamed-up.com/short/langzeitdaten-zum-einsatz-von-garadacimab-in-der-prophylaxe-des-hereditaren-angioodemshttps://streamed-up.com/short/post-hoc-analyse-zum-wirkeintritt-von-garadacimab-in-der-prophylaxe-des-hereditaren-angioodemshttps://streamed-up.com/short/sicherheit-und-immunantwort-eines-multikomponentenimpfstoffes-gegen-influenza-und-covid-19-bei-erwachsenen-50-jahrenhttps://streamed-up.com/short/umstellung-auf-lcp-tacrolimus-reduziert-die-nephrotoxizitaet-nach-lebertransplantationhttps://streamed-up.com/short/teprotumumab-in-der-therapie-der-endokrinen-orbitopathie-mit-laengerer-krankheitsdauer-und-rezidivhttps://streamed-up.com/short/resmetirom-in-der-therapie-der-mash-mit-leberfibrosehttps://streamed-up.com/short/blutungsprophylaxe-mit-marstacimab-hympavzi-bei-haemophilie-ab-ohne-inhibitorenhttps://streamed-up.com/short/zeitlich-begrenzte-therapieregime-mit-acalabrutinib-calquence-in-der-erstlinientherapie-der-unbehandelten-chronischen-lymphatischen-leukaemiehttps://streamed-up.com/short/bulevirtid-hepcludex-in-der-therapie-der-chronischen-hepatitis-dhttps://streamed-up.com/short/durvalumab-imfinzi-plus-tremelimumab-imjudo-in-kombination-mit-chemotherapie-in-der-erstlinienbehandlung-des-metastasierten-nsclchttps://streamed-up.com/short/nemolizumab-bei-atopischer-dermatitis-ergebnisse-der-offenen-arcadia-verlaengerungsstudie-nach-2-jahrenhttps://streamed-up.com/short/orales-iptacopan-in-der-therapie-der-c3-glomerulonephritis-ergebnisse-der-phase-3-studie-appear-c3ghttps://streamed-up.com/short/lenvatinib-plus-pembrolizumab-zur-behandlung-des-fortgeschrittenen-endometriumkarzinoms-primaere-wirksamkeits-und-vertraeglichkeitsergebnisse-der-phase-3-studie-keynote-775https://streamed-up.com/short/lenvatinib-plus-pembrolizumab-zur-behandlung-des-fortgeschrittenen-endometriumkarzinoms-langzeit-follow-up-und-subgruppenanalyse-der-phase-3-studie-keynote-775https://streamed-up.com/short/schnelle-juckreizlinderung-mit-nemolizumab-bei-atopischer-dermatitis-und-prurigo-nodularis-post-hoc-analyse-aus-vier-phase-3-studienhttps://streamed-up.com/short/7-jahres-daten-zur-sicherheit-und-wirksamkeit-von-somapacitan-bei-kindern-mit-wachstumshormonmangel-finale-ergebnisse-der-real-3-studiehttps://streamed-up.com/short/acalabrutinib-calquence-in-kombination-mit-bendamustin-rituximab-zur-therapie-des-unbehandelten-mantelzell-lymphomshttps://streamed-up.com/short/nephroprotektion-durch-umstellung-von-fast-metabolizern-auf-envarsus-2https://streamed-up.com/short/wirksamkeit-einer-webbasierten-intervention-bei-depressiven-stoerungen-dreiarmige-randomisierte-kontrollierte-studie-zum-vergleich-von-angeleiteter-und-nicht-angeleiteter-selbsthilfe-mit-einer-wartelistenkontrollgruppehttps://streamed-up.com/short/blutungsprophylaxe-mit-marstacimab-hympavzi-bei-haemophilie-ab-mit-inhibitoren